Cointime

BlueRock Therapeutics

company

About

It is a regenerative medicine company.

  • 101 - 250

Highlights

Total Funding Amount
$225M
Funding Rounds
1
Investors
2
Investments
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$225M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active

BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225M
BlueRock Therapeutics has raised a total of $225M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2016 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2016 Series A $225M 2 Bayer
Versant Ventures 		— Detail

Investments

Number of Investments
Number of Lead Investments
1
0
BlueRock Therapeutics has made 1 investments. Their most recent investment was on Nov 6, 2019, when Digits raised $10.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 6, 2019 Digits
Series A $10.50M Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
2
2
BlueRock Therapeutics is funded by 2 investors. Bayer and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Bayer Yes Series A
Versant Ventures Yes Series A
Cointime
Insight
Features
RSS
Company